Jefferies lowers Kratos Defense stock price target on margin outlook

Jefferies cut its Kratos price target to $50 from $68 but maintained a Buy rating, citing a $2.7 billion backlog, up 79%, and a 2.2x book-to-bill ratio. Kratos reported Q3 2026 adjusted EPS of $0.24 versus $0.21 expected and revenue of about $471.8 million versus $470.28 million expected; revenue rose 35.7% year over year and adjusted EBITDA increased 65% to about $51 million. Analysts flagged cash use, working capital and capital spending, with positive free cash flow not expected until 2029; 2027 margin expansion of about 100 bps to roughly 11% is projected.

Analysis

KTOS offers backlog visibility, but backlog is not cash: the key underwriting question is whether production ramps convert into revenue without a disproportionate rise in inventory, receivables, and capex. A continuing resolution could delay customer awards or delivery timing, making the near-term cash profile worse even if demand remains intact. That creates a potential valuation mismatch: investors may capitalize book-to-bill as durable growth while discounting the working-capital burden until free cash flow arrives.

Over the next 1–3 months, watch guidance revisions, contract timing, and quarterly cash conversion rather than headline order growth. Over 6–18 months, successful Valkyrie and engine scaling could support margin expansion and strengthen KTOS’s position against other unmanned-aircraft and defense suppliers; execution delays could instead leave fixed investment ahead of revenue. The divergent analyst target cuts are a reminder that the debate is valuation and conversion, not simply demand.

Contrarian balance: the long-duration ramp may be underappreciated if investors focus too heavily on delayed free cash flow, but the near-term risk is that strong bookings mask a longer cash trough. Falsify the cautious view with improving operating cash flow and working-capital intensity alongside on-time production; falsify the constructive view with a backlog-to-revenue slowdown, reduced guidance, or further cash-use deterioration.

Key Decisions for Investors

• Do not chase the earnings beat on its own. Keep KTOS exposure measured until another reporting period shows backlog conversion without worsening working-capital intensity.
• Consider adding on weakness only if production milestones hold and guidance is maintained; define the thesis break as a material guidance reduction, delayed program ramp, or sustained deterioration in cash conversion.
• For a relative-value expression, favor diversified defense exposure over an outright KTOS overweight while the cash-flow path remains distant; revisit after the next quarterly cash-flow and contract-conversion update.
• Track continuing-resolution developments and quarterly receivables, inventory, and capex: these are the near-term indicators most likely to distinguish timing pressure from a genuine execution problem.